区间特异性似然比改善不同分析平台抗磷脂抗体检测解读
该回顾性单中心诊断准确性研究纳入351例APS患者和197例对照,比较ELISA、CLIA和PMAT检测aCL和aβ2GPI的分析与诊断性能。自动化平台相关性好且阳性率高于ELISA,PMAT在血栓性APS中诊断准确性最高。区间特异性似然比随抗体浓度升高而增加,在特异性≥99%阈值时尤为明显,可提供优于二分cut-off的概率信息。
要点
- 自动化平台(CLIA、PMAT)与ELISA强相关,PMAT诊断血栓性APS准确性最高。
- 抗体浓度越高区间特异性似然比越大,特异性≥99%阈值时更显著。
- 区间特异性似然比可跨平台提供超越二分cut-off的风险分层信息。
核心结论
- 自动化平台(含PMAT)是aPL检测分析稳健且临床可靠的方法,可作为常规ELISA的有效替代。
- 区间特异性似然比解读可提供超越二分cut-off的临床相关概率信息,可能改善APS实验室风险分层。
研究设计与样本
- 回顾性单中心诊断准确性研究,纳入351例APS患者(238例血栓性、113例产科APS)和197例对照。
- 使用ELISA、CLIA和PMAT检测IgG/IgM aCL和aβ2GPI,以相关分析评估分析一致性,ROC分析评估诊断性能。
- 采用预设特异性阈值(90%、95%、≥99%)计算区间特异性似然比。
主要发现
- 所有分析平台间呈强相关(p<0.001),CLIA与PMAT一致性最高。
- 自动化平台阳性率高于ELISA,尤其IgM同种型。
- PMAT在血栓性APS中诊断准确性最高:IgG aCL 0.810、IgG aβ2GPI 0.816、IgM aβ2GPI 0.848。
- 抗体浓度升高与区间特异性似然比逐步增高相关,在特异性≥99%阈值时尤为明显。
- 产科APS中诊断性能较低。
关键数值与推荐
- 区间特异性似然比基于预设特异性阈值90%、95%和≥99%计算。
- PMAT在血栓性APS中的ROC曲线下面积:IgG aCL 0.810、IgG aβ2GPI 0.816、IgM aβ2GPI 0.848。
临床怎么用
- 实验室可考虑用自动化平台(CLIA或PMAT)替代ELISA进行aPL检测。
- 解读aPL定量结果时可采用区间特异性似然比,结合抗体浓度和特异性阈值进行风险分层。
局限性
- 回顾性单中心设计可能限制推广性。
- 产科APS中诊断性能较低,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Antiphospholipid antibodies (aPL) are essential biomarkers for classification, diagnosis, and risk stratification of antiphospholipid syndrome (APS). Although automated analytical platforms, such as chemiluminescent immunoassay (CLIA), and particle-based multi-analyte technology (PMAT), are increasingly implemented in routine laboratories, uncertainty remains regarding their diagnostic performance and interpretation of quantitative antibody results. We compared ELISA, CLIA, and PMAT for aPL detection and evaluated clinical utility of interval-specific likelihood ratios (LRs). METHODS: In this retrospective single-center diagnostic accuracy study, 351 patients with APS (238 thrombotic and 113 obstetric APS) and 197 controls were included. IgG and IgM anticardiolipin (aCL) and anti-β2-glycoprotein I (aβ2GPI) antibodies were measured using ELISA, CLIA, and PMAT. Analytical agreement was assessed by correlation analysis, and diagnostic performance by ROC analysis. Interval-specific LRs were calculated using predefined specificity thresholds (90 %, 95 %, and ≥99 %). RESULTS: Strong correlations were observed among all analytical platforms (p<0.001), with the highest agreement found between CLIA and PMAT. Automated platforms showed higher positivity rates than ELISA, particularly for IgM isotypes. PMAT achieved the highest diagnostic accuracy in thrombotic APS for IgG aCL (0.810), IgG aβ2GPI (0.816), and IgM aβ2GPI (0.848). Increasing antibody concentrations were associated with progressively higher interval-specific LRs, especially at specificity thresholds ≥99 %. Diagnostic performance was lower in obstetric APS. CONCLUSIONS: Automated platforms, including PMAT represent analytically robust and clinically reliable methodologies for aPL testing, and represent valid alternatives to conventional ELISA assays. Interval-specific LR interpretation provides clinically relevant probabilistic information beyond dichotomous cut-offs, and may improve laboratory-based risk stratification in APS across analytical platforms.
引用
- Irure-Ventura J, Gálvez-Sánchez R, Mota-Pérez N, et al. Interval-specific likelihood ratios improve interpretation of antiphospholipid antibody testing across different analytical platforms. Clin Chem Lab Med. 2026. PMID: 42622511. doi:10.1515/cclm-2026-0870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。